Application 201442

Type: ANDA
Sponsor: ANCHEN PHARMS

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	LUBIPROSTONE	LUBIPROSTONE	CAPSULE;ORAL	8MCG	No	No
002	LUBIPROSTONE	LUBIPROSTONE	CAPSULE;ORAL	24MCG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A201442-001	LUBIPROSTONE	LUBIPROSTONE	8MCG	CAPSULE / ORAL			2022-06-27
A201442-002	LUBIPROSTONE	LUBIPROSTONE	24MCG	CAPSULE / ORAL			2022-06-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 58 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A201442-001	LUBIPROSTONE	8MCG	CAPSULE / ORAL	2022-06-27	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A201442-002	LUBIPROSTONE	24MCG	CAPSULE / ORAL	2022-06-27	`9b2671bbb829…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-10-28 04:53 UTC	2022-10	A201442-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A201442-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A201442-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A201442-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A201442-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A201442-002	AB	1	`cb3db0bc1861…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 26 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lubiprostone	LUBIPROSTONE	Sun Pharmaceutical Industries, Inc.	f06d76d2-028a-629f-e053-2995a90a80f5	2026-07-14	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Par Health USA, LLC	9d958b58-6c4f-4bb1-8660-cf5eac256440	2026-07-10	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	SpecGx LLC	cdf79a5a-6857-4a32-8c54-8c435d1a7535	2026-07-10	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Amitiza	LUBIPROSTONE	SpecGx LLC	164a2b47-0a52-4bb4-9e71-5342c2e951f4	2026-07-10	Warnings, Adverse reactions	Name fallback generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Dr. Reddy's Laboratories Inc.	006b8b6c-f0eb-4246-87da-67582984b0e4	2026-07-10	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Proficient Rx LP	5fd683a5-87ff-42b8-a8c8-fff81625f67f	2026-07-01	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Golden State Medical Supply, Inc.	f4d506e0-1322-4fc4-e053-2995a90ac880	2026-04-16	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	American Health Packaging	3014dd6d-9c05-479d-b79d-7a49f78a1ce5	2026-03-24	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
LUBIPROSTONE	LUBIPROSTONE	Natco Pharma USA LLC	10c7b62d-6c39-453c-8d9a-2f441725bc3b	2025-12-22	Warnings, Adverse reactions	Name fallback brand name: LUBIPROSTONE generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Northstar Rx LLC	1626ac65-ea12-421b-9780-bfdb50a39e1a	2025-06-25	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Asclemed USA, Inc.	5797e57c-4e87-48d9-b16d-992f64db594f	2025-02-06	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Asclemed USA, Inc.	f5653f3b-c3c8-487c-bc00-3770985aa5ee	2025-01-28	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Amitza	LUBIPROSTONE	Direct_Rx	f2121338-9586-161d-e053-2995a90af908	2025-01-22	Warnings, Adverse reactions	Name fallback generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Camber Pharmaceuticals, Inc.	6d973d7d-a43e-4495-b618-a8ad3142683d	2025-01-22	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Direct Rx	2bd6f613-64d0-0291-e063-6294a90a0238	2025-01-16	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Advanced Rx of Tennessee, LLC	031149b9-c709-de1f-e063-6394a90a6d81	2024-12-31	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Advanced Rx of Tennessee, LLC	031170a4-5f7d-b371-e063-6394a90ae21d	2024-12-31	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Quality Care Products, LLC	9bffe7c4-40f2-4490-a32f-15d525000928	2024-12-19	Warnings, Adverse reactions	Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Lubiprostone	LUBIPROSTONE	Zydus Lifesciences Limited	81f9c9de-f89d-4ab0-a8ca-18d3691e42f9	2024-11-30		Name fallback brand name: Lubiprostone generic name: LUBIPROSTONE
Amitiza	LUBIPROSTONE	Takeda Pharmaceuticals America, Inc.	d474ac6a-444d-4aa6-9986-24be6fcf811d	2024-01-18	Warnings, Adverse reactions	Name fallback generic name: LUBIPROSTONE

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 2 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
10370-266	Lubiprostone	Lubiprostone	Par Pharmaceutical, Inc.	ANDA	Current
10370-267	Lubiprostone	Lubiprostone	Par Pharmaceutical, Inc.	ANDA	Current